Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension
Status:
NOT_YET_RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
Open-label pilot study of early inhaled nitric oxide (iNO) for patients developing de novo pulmonary hypertension during Acute Respiratory Distress Syndrome (ARDS.) The study aims to determine whether iNO has possible hemodynamic and clinical benefits when given early in the course of ARDS to patients with evidence of elevated pulmonary artery pressure.